New Partnership Aims To Develop AIDS Vaccine

EPIDEMICS

London (AFP) Jun 21, 2005
The International AIDS Vaccine Initiative said Tuesday it is teaming up with a major international pharmaceutical manufacturer to develop an AIDS vaccine using new technology.

In a statment, the IAVI said its first-of-its-kind partnership with GlaxoSmithKline Biologicals would "facilitate early research and development of GSK's non-human primate adenovirus vaccine vector as an enabling component of an effective AIDS vaccine".

Under the agreement, announced in London, IAVI and GlaxoSmithKline will jointly develop the technology, which uses non-infectious vaccine vectors to stimulate specific immune responses directed against HIV, the virus that leads to AIDS.

The vectors are derived from adenoviruses, originally isolated from non-human primates, which have been engineered to be non-infectious and capable of efficiently delivering genes expressing HIV proteins to the immune system.

"We hope this will be the beginning of a long term partnership that brings together some of the most promising technologies in the field," said Seth Berkley, president and chief executive of the IAVI.

GlaxoSmithKline said joint research would initially focus on vaccines "designed to elicit immune responses against variants of HIV that circulate predominantly in Africa".

Once pre-clinical evaluations are completed, GlaxoSmithKline and the IAVI intend to carry out clinical trials.

The non-human primate adenovirus vector technology was derived from research conducted by scientists at the University of Pennsylvania in the United States and licensed to GlaxoSmithKline.

Financial terms of Tuesday's agreement were not disclosed.

EPIDEMICS

'Molecular Zipper' Holds Clues To Alzheimer's, Parkinson's, Mad Cow Disease

Los Angeles CA (SPX) Jun 10, 2005
An international team of chemists and molecular biologists has discovered a fundamental molecular mechanism that seems to play an important role in Alzheimer's disease, Parkinson's disease, mad cow disease and two-dozen other degenerative and fatal diseases.

DISASTER MANAGEMENT EO To Improve Risk Management Of Landslides, Floods In Alpine Regions Lessons On Dealing With Disasters For China Kids As Flood Toll Hits 103 GINA Collaboration To Boost Response To Summer Fires Death Toll Rises To 204 From China's Torrential Rains, Floods	CLIMATE SCIENCE EU Greenhouse Gas Emissions On The Rise Many Of 2 Billion Dryland Dwellers At Risk As Land Degrades Spanish Government Appeals For Restraint With Air Conditioning Shake And Bake For SMOS
EARTH OBSERVATION Street-Level London Air Pollution Warnings Coming Via Mobile Phones A Plan Of Action For EarthCARE Hurricanes To Intensify As Earth Warms America's Newest USAF Weather Satellite Delivered To Launch Site	ENERGY TECH New Study: Why Solar Cells Lose Potency New Hope For Reducing Greenhouse Gas Emissions In Australia Analysis: Bush Pushes Energy Legislation 'Plastic Oil' Could Improve Fuel Economy In Cars, Chemists Say
EPIDEMICS New Partnership Aims To Develop AIDS Vaccine 'Molecular Zipper' Holds Clues To Alzheimer's, Parkinson's, Mad Cow Disease UIC Developing Drug For SARS	FLORA AND FAUNA Vietnam War Technology Could Aid Elephant Conservation Microbes In Colorful Yellowstone Hot Springs Fueled By Hydrogen SAfrican Government Consults Scientists On Elephant Culling NASA Analyzes Prehistoric Predator From The Past
FROTH AND BUBBLE	ABOUT US Punctuated Evolution In The Human Genome

The content herein, unless otherwise known to be public domain, are Copyright 1995-2006 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA PortalReports are copyright European Space Agency. All NASA sourced material is public domain. Additionalcopyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement